Volume | 48,356 |
|
|||||
News | - | ||||||
Day High | 3.79 | Low High |
|||||
Day Low | 3.695 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Design Therapeutics Inc | DSGN | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
3.77 | 3.695 | 3.79 | 3.76 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
511 | 48,356 | $ 3.76 | $ 181,967 | - | 1.94 - 8.47 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
13:23:04 | 13 | $ 3.79 | USD |
Design Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
211.69M | 56.00M | - | 0 | -66.86M | -1.19 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Design Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical DSGN Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 3.72 | 3.965 | 3.51 | 3.74 | 241,909 | 0.06 | 1.61% |
1 Month | 4.04 | 4.145 | 3.45 | 3.78 | 291,303 | -0.26 | -6.44% |
3 Months | 2.41 | 4.145 | 2.245 | 3.29 | 271,187 | 1.37 | 56.85% |
6 Months | 2.07 | 4.145 | 1.96 | 2.69 | 342,201 | 1.71 | 82.61% |
1 Year | 6.32 | 8.47 | 1.94 | 3.03 | 467,830 | -2.54 | -40.19% |
3 Years | 19.23 | 29.16 | 1.94 | 8.50 | 328,236 | -15.45 | -80.34% |
5 Years | 28.00 | 50.00 | 1.94 | 8.94 | 326,535 | -24.22 | -86.50% |
Design Therapeutics Description
Design Therapeutics Inc is a preclinical-stage biopharmaceutical company. It is a pioneering novel small-molecule therapeutic candidate, called gene-targeted chimera, that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases. |